Akoya Biosciences, Inc.
AKYA
$1.26
-$0.04-3.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 30.10% | 12.57% | 18.81% | 20.96% | 6.90% |
| Total Depreciation and Amortization | -16.09% | -13.90% | -8.95% | 7.59% | 15.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -48.16% | -2.88% | -3.10% | 18.66% | 106.61% |
| Change in Net Operating Assets | 84.46% | 4.10% | -28.48% | -508.93% | -1,164.05% |
| Cash from Operations | 41.32% | 13.35% | 15.58% | 4.72% | 6.07% |
| Capital Expenditure | 49.44% | 32.77% | 48.88% | 65.05% | 47.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 188.86% | -408.50% | -184.43% | -194.59% | -21,342.04% |
| Cash from Investing | 178.99% | -818.58% | -204.86% | -220.54% | -665.99% |
| Total Debt Issued | -- | -- | 0.00% | -47.06% | -64.00% |
| Total Debt Repaid | -44.01% | -51.18% | -6.22% | -13.26% | -10.26% |
| Issuance of Common Stock | -99.87% | -99.81% | -99.83% | -99.79% | 10,631.33% |
| Repurchase of Common Stock | 4.70% | -127.66% | -127.66% | -127.66% | -58.51% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.47% | -5.70% | 30.26% | 31.15% | 27.89% |
| Cash from Financing | -105.30% | -105.64% | -85.08% | -87.33% | 100.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.61% | -867.96% | -345.21% | -280.82% | -38.95% |